Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • pharma-news
    • CDSCO lays down the...

    CDSCO lays down the Timeline for testing of various classes of New drugs

    Medical Dialogues BureauWritten by Medical Dialogues Bureau Published On 2020-03-19T14:33:06+05:30  |  Updated On 19 March 2020 2:57 PM IST
    CDSCO lays down the Timeline for testing of various classes of New drugs

    New Delhi: To streamline the process of testing for approval of all categories of drugs, the Central Drugs Standard Control Organization(CDSCO), Directorate General of Health Services has now specified particular timelines for testing by Central Government Laboratories

    The timeline was released in a notice by Dr V G Somani, Drugs Controller General (India) (DCGI) to all Government Laboratories.

    Under the New Drugs and Clinical Trials Rules, 2019, CDSCO grants permission for import/manufacture of new drugs for sale and distribution. One of the requirements is testing of the new drugs in the Central Government Laboratories before their approval.

    "Concerns have been raised regarding the requirement of such laboratory testing of new drugs which are pharmacopoeial products or which are additional strengths of an already approved new drug," the notice stated

    In this regard, to streamline the new drug approval process, it has been decided that, testing will be carried out by the Central Government Laboratories as per the following timelines unless otherwise, there is any specific issue involved relating to testing of the drug

    Categories of new drug

    Timeline

    New drugs already approved

    4 weeks

    New drugs which are pharmacopoeial

    6 weeks

    Other new drugs

    8 weeks

    For full details click on the following link
    https://business.medicaldialogues.in/pdf_upload/pdf_upload-125582.pdf

    cdscocentral-drugs-standard-control-organization

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok